OR WAIT null SECS
March 10, 2022
Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.
January 11, 2022
The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.
December 03, 2021
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
July 09, 2021
Tezepelumab, being developed by AstraZeneca in collaboration with Amgen, reduced asthma exacerbations in Phase II and III clinical trials.
May 07, 2021
Eli Lilly and Company has partnered with leading diabetes tech firms to offer app compatibility with insulin smart pens to streamline diabetes management with automated data collection.
May 02, 2021
Vaccine development is inherently challenging; however, in light of the COVID-19 pandemic, innovations have been prioritized, leading to accelerated development processes.
April 02, 2021
The inhaled route of administration for biologics is experiencing renewed interest, particularly in light of the COVID-19 pandemic.
September 01, 2020
Current and newer biologic modalities pose increasingly complex challenges to the detection and characterization of protein aggregates.
July 02, 2020
Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.
RNA is easier to manipulate than DNA but challenging to deliver to the right cells.